How much funding has Metis Pharma raised?

Metis Pharma has raised $236.0M in total funding, most recently a Series B round.

Who are Metis Pharma's investors?

Metis Pharma's investors include PICC Capital Investment, China Life Equity, Frees Fund, 5Y Capital, Sequoia China.

When was Metis Pharma founded?

Metis Pharma was founded in 2019.

Where is Metis Pharma headquartered?

Metis Pharma is headquartered in Hangzhou, China.

What industry is Metis Pharma in?

Metis Pharma operates in Artificial Intelligence, Biotech.

How many employees does Metis Pharma have?

Metis Pharma has 51-200 employees.

Metis Pharma

IPO

Hangzhou, China · Founded 2019 · $236.0M raised

Artificial Intelligence

Biotech

Headquarters: Hangzhou
Employees: 51–200
Founded: 2019
Business Model: B2B

Website: metispharma.com
Total Funding: $236.0M
Last Round: $150.0M Series BApr 2022
Rounds: 2

About

METiS Pharmaceuticals is an AI-driven innovative biotechnology company that harnesses targeted drug delivery technology to develop more effective drugs for patients. Through the integration of cutting-edge artificial intelligence with traditional pharmaceutical R&D, METiS accelerates the discovery and development of innovative drugs in a more efficient and precise manner, while leveraging its core technology platforms to support the broader pharmaceutical ecosystem. The company has developed the AiLNP platform for AI-designed nanoparticle drug delivery and has received FDA Orphan Drug designation for its hepatocellular carcinoma candidate.

Summary

Metis Pharma is an Artificial Intelligence company based in Hangzhou, China, founded in 2019. It has raised $236.0M in total across 2 rounds, most recently a $150.0M Series B round in Apr 2022. Investors include PICC Capital Investment, China Life Equity and Frees Fund.